emeis Société anonyme (BATS-CHIXE:EMEISP) - Aandelenkoers, Nieuws & Analyse

EMEISP Overzicht aandelen

emeis Société anonyme exploiteert rusthuizen, instellingen voor begeleid wonen, postacute en revalidatieziekenhuizen en psychiatrische ziekenhuizen.

Over het bedrijf

EMEISP fundamentele analyse
Sneeuwvlok Score
Waardering	4/6
Toekomstige groei	1/6
Prestaties in het verleden	2/6
Financiële gezondheid	0/6
Dividenden	0/6

Beloningen

Trading at 95.5% below our estimate of its fair value

Revenue is forecast to grow 6.27% per year

Became profitable this year

Risicoanalyse

Shareholders have been substantially diluted in the past year

Debt is not well covered by operating cash flow

Earnings are forecast to decline by an average of 106.1% per year for the next 3 years

High level of non-cash earnings

+ 1 meer risico

emeis Société anonyme Concurrenten

CVS Group

AIM:CVSG

UK£688.0m

Spire Healthcare Group

LSE:SPI

UK£884.4m

Mediclinic International

LSE:MDC

UK£3.7b

Craneware

AIM:CRW

UK£697.3m

Prijsgeschiedenis en prestaties

Overzicht van alle hoogtepunten, veranderingen en prijsdalingen voor emeis Société anonyme
Historische aandelenkoersen
Huidige aandelenkoers	€13.34
52 Week Hoogtepunt	€17.10
52 Week Laag	€10.92
Bèta	0.72
11 maand verandering	0%
3 maanden verandering	0.99%
1 Jaar Verandering	n/a
33 jaar verandering	-99.99%
5 jaar verandering	-99.99%
Verandering sinds IPO	-99.95%

Recent nieuws en updates

Recent updates

Rendement voor aandeelhouders

	EMEISP	GB Healthcare	GB Markt
7D	0%	1.4%	-1.3%
1Y	n/a	-15.0%	8.9%

Rendement versus industrie: Insufficient data to determine how EMEISP performed against the UK Healthcare industry.

Rendement versus markt: Insufficient data to determine how EMEISP performed against the UK Market.

Prijsvolatiliteit

Is EMEISP's price volatile compared to industry and market?
EMEISP volatility
EMEISP Average Weekly Movement	n/a
Healthcare Industry Average Movement	6.4%
Market Average Movement	4.7%
10% most volatile stocks in GB Market	9.5%
10% least volatile stocks in GB Market	2.6%

Stabiele aandelenkoers: EMEISP's share price has been volatile over the past 3 months compared to the UK market.

Volatiliteit in de loop van de tijd: Insufficient data to determine EMEISP's volatility change over the past year.

Over het bedrijf

Opgericht	Werknemers	CEO	Website
1989	78,000	Laurent Guillot	www.emeis-group.com

emeis Société anonyme exploiteert verpleeghuizen, instellingen voor begeleid wonen, postacute en revalidatieziekenhuizen en psychiatrische ziekenhuizen. De verpleeghuisfaciliteiten bieden persoonlijke ondersteuningsdiensten en logistieke en residentiële diensten, waaronder accommodatie, maaltijden en was- en schoonmaakdiensten, evenals diverse dagelijkse evenementen, entertainment en therapeutische workshopdiensten. De postacute en revalidatieziekenhuizen van het bedrijf bieden diensten voor geriatrie, musculoskeletale aandoeningen, zenuwstelsel, cardiovasculaire aandoeningen, hematologie en oncologie, evenals patiënten in een persisterende vegetatieve toestand of in een minimaal bewuste staat.

emeis Société anonyme Samenvatting

Hoe verhouden de winst en inkomsten van emeis Société anonyme zich tot de beurswaarde?
EMEISP fundamentele statistieken
Marktkapitalisatie	€825.82m
Inkomsten(TTM)	€1.47b
Inkomsten(TTM)	€5.43b

0.6x

Koers/Winstverhouding

0.2x

P/S-verhouding

Is EMEISP overgewaardeerd?

Zie Reële waarde en waarderingsanalyse

Inkomsten en omzet

Belangrijkste winstgevendheidsstatistieken uit het laatste winstverslag (TTM)
EMEISP resultatenrekening (TTM)
Inkomsten	€5.43b
Kosten van inkomsten	€4.78b
Brutowinst	€648.53m
Overige uitgaven	-€820.05m
Inkomsten	€1.47b

Laatst gerapporteerde inkomsten

Jun 30, 2024

Volgende inkomensdatum

n.v.t.

Winst per aandeel (EPS)	9.12
Brutomarge	11.94%
Nettowinstmarge	27.04%
Schuld/Eigen Vermogen Verhouding	233.1%

Hoe presteerde EMEISP op de lange termijn?

Bekijk historische prestaties en vergelijking

EMEISP Overzicht aandelen

Beloningen

Risicoanalyse

emeis Société anonyme Concurrenten

AIM:CVSG

UK£688.0m

LSE:SPI

UK£884.4m

LSE:MDC

UK£3.7b

AIM:CRW

UK£697.3m

Prijsgeschiedenis en prestaties

Recent nieuws en updates

Orpea SA, Annual General Meeting, Jun 25, 2024

Full year 2023 earnings released: EPS: €0.13 (vs €62,330 loss in FY 2022)

New major risk - Revenue and earnings growth

Orpea SA has completed a Follow-on Equity Offering in the amount of €390.019673 million.

Orpea SA announced that it expects to receive €390.019673 million in funding

Orpea SA announced that it expects to receive €390.019673 million in funding

Recent updates

Orpea SA, Annual General Meeting, Jun 25, 2024

Full year 2023 earnings released: EPS: €0.13 (vs €62,330 loss in FY 2022)

New major risk - Revenue and earnings growth

Orpea SA has completed a Follow-on Equity Offering in the amount of €390.019673 million.

Orpea SA announced that it expects to receive €390.019673 million in funding

Orpea SA announced that it expects to receive €390.019673 million in funding

Orpea SA announced that it expects to receive €390.019673 million in funding

Orpea Sa Appoints Méka Brunel as Independent Non-Executive Director

Orpea SA has filed a Follow-on Equity Offering in the amount of €1.2 billion.

Orpea SA(ENXTPA:ORPDS) dropped from SBF 120 Index

Orpea SA has filed a Follow-on Equity Offering in the amount of €3.884212 billion.

Orpea SA, Annual General Meeting, Dec 22, 2023

Orpea SA Provides Earnings Guidance for the Full Year 2023; Provides Consolidated Revenue Guidance for the Years 2024 and 2025

Orpea SA to Report First Half, 2023 Results on Oct 11, 2023

New minor risk - Market cap size

An Unknown buyer acquired portfolio of four recently built retirement homes In Austria from Orpea SA (ENXTPA:ORP) for €55 million.

An Unknown buyer acquired portfolio of four recently built retirement homes In Austria from Orpea SA (ENXTPA:ORP) for €55 million.

Orpea SA Provides Financial Guidance for 2023

New major risk - Negative shareholders equity

Full year 2022 earnings released: €62.33 loss per share (vs €1.01 profit in FY 2021)

Adoro SIA signed an agreement to acquire Retirement Home and Entire Scope of Activities in Latvia from Orpea SA (ENXTPA:ORP).

Caisse des Dépôts et Consignations and a representative group of creditors agreed to acquire a 50.2% stake in Carver Maritime Manatee.

Orpea Sa Announces Revenue Guidance for Year Ending 31 December 2022

First half 2022 earnings released: EPS: €0 (vs €1.59 in 1H 2021)

Orpea SA(ENXTPA:ORP) dropped from FTSE All-World Index (USD)

Investor sentiment deteriorated over the past week

Orpea S.A Appoints Laure Duhot as Non-Executive Director

Investor sentiment improved over the past week

Syntrus Achmea Real Estate & Finance signed agreement to acquire portfolio of 32 retirement homes located in the Netherlands from Orpea SA (ENXTPA:ORP) for EUR 125 million.

ORPEA Announces Major Changes in its Board of Directors

Full year 2021 earnings released: EPS: €1.01 (vs €2.48 in FY 2020)

Orpea SA to Report First Half, 2022 Results on Sep 21, 2022

Investor sentiment deteriorated over the past week

ORPEA Appoints Laurent Guillot as CEO

Orpea Announces CEO Changes

Investor sentiment deteriorated over the past week

Orpea Provides Earnings Guidance for the Full Year 2021

First half 2021 earnings released

Upcoming dividend of €0.90 per share

Orpea SA Reiterate Revenue Guidance for the Full Year of Fiscal 2021

Full year 2020 earnings released

Orpea SA Proposes Dividend for Financial Year 2020

New 90-day low: €102

Orpea SA to Report Fiscal Year 2020 Results on Mar 16, 2021

New 90-day high: €109

ORPEA Société Anonyme (ENXTPA:ORP) agreed to acquire remaining 55% stake in Groupe Sinoue - Sarl.

Orpea SA (ENXTPA:ORP) acquired 50% stake in Brindley Healthcare Limited.

Icade SA (ENXTPA : ICAD) agreed to acquire Portfolio of 9 Healthcare Facilities in Germany & France from Orpea SA (ENXTPA : ORP) for €145 million.

Rendement voor aandeelhouders

Prijsvolatiliteit

Over het bedrijf

emeis Société anonyme Samenvatting

0.6x

0.2x

Inkomsten en omzet